Skip to main content

ISOP ACoP 2025 Annual Conference Main banner

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

M
M-040
Machine Learning and Chemical Language Model-Based QSAR Models for Predicting Plasma and Tissue Half-Lives of Drugs in Cattle Across Various Administration Routes

Favorite
M-040
Machine Learning and Chemical Language Model-Based QSAR Models for Predicting Plasma and Tissue Half-Lives of Drugs in Cattle Across Various Administration Routes

Favorite
S-039
Machine Learning and Mechanistic Modeling to Predict Intravenous Pharmacokinetic Profiles in Humans

Favorite
M-076
Machine learning approach links QSP virtual populations with key lesion types and clinical scoring in hidradenitis suppurativa

Favorite
M-051
Machine Learning Augmented Tumor Growth and Survival Models: Insights from Hepatocellular Carcinoma Data

Favorite
S-068
Machine learning for exploratory data analysis and model diagnosis in oncology

Favorite
S-093
Machine Learning-Integrated Physiology-Based Pharmacokinetic Modeling for Optimizing Nanoparticle Design

Favorite
T-067
Mathematical Modeling of Tumor Response to Fibroblast Activation Protein (FAP)-Targeted Radiopharmaceutical Therapy

Favorite
S-102
Mathematical Modeling to Optimize Receptor Occupancy Assay Development for Isatuximab

Favorite
S-037
Mechanism-based PBPK Modeling Reveals Nonlinear Brain Pharmacokinetics of Fluvoxamine: Roles of Active Influx and Brain Metabolism

Favorite
M-036
Mechanistic Insights by Combining Quantitative Systems Pharmacology (QSP) and Machine Learning: An Inflammatory Bowel Disease Case Study

Favorite
S-035
Mechanistic insights on diverse in vivo tumor efficacy outcomes for bispecific T-cell engagers using a quantitative systems pharmacology model

Favorite
M-064
Mechanistic Insights Uncover Novel Therapeutic Targets in Cardiac Hypertrophy

Favorite
T-075
Mechanistic Modeling and Unsupervised Learning Reveal Drivers of Inter-Individual Variability in COVID-19 Vaccine-Induced Immunity

Favorite
T-092
Mechanistic Modeling of Bispecific Antibody Combination Therapy to Optimize TumorKilling in Cancer Immunotherapy

Favorite
T-102
Methylprednisolone PK/PD in a Rat Model of Cytokine Release Syndrome

Favorite
S-109
Mixed Effects Modeling of Diurnal Cortisol Dysregulation in Long COVID

Favorite
S-057
mlxDesignEval: A novel R package for design evaluation based on MonolixSuite, and its comparison to popED and PFIM

Favorite
M-049
Model Platform to Predict Overall Survival for Patients with Relapsed and Refractory Multiple Myeloma

Favorite
T-068
Model selection for precision dosing: Comparison of Machine Learning and Evidence-plus-Expertise Algorithms

Favorite
S-082
Model-Based Approach to Support Nivolumab Subcutaneous Dose Selection in Pediatric Patients (12 to <18 Years) in Multiple Solid Tumor Indications

Favorite
M-086
Model-Based Evaluation of Lumasiran Plasma and Liver Pharmacokinetics in Non-Human Primates

Favorite
M-043
Model-based meta-analysis of objective response rate and overall survival in recurrent/metastatic head and neck squamous cell carcinoma

Favorite
M-066
Model-informed Assessment of the Impact of Relaxing the high-sensitivity C-reactive protein Inclusion Criteria on Patient Enrollment and Efficacy Signal in Rheumatoid Arthritis Clinical Trial Design

Favorite
T-043
Model-informed Clinical Trial Design for Autosomal Dominant Tubulointerstitial Kidney Disease: Integrating Disease Progression and Trial Simulation

Favorite
T-008
Model-informed dose priming strategy for T cell engagers: Leveraging early clinical data to mitigate CRS

Favorite
T-008
Model-informed dose priming strategy for T cell engagers: Leveraging early clinical data to mitigate CRS

Favorite
S-104
Model-Informed Dose Selection for mRNA-3927 in Participants with Propionic Acidemia (PA)

Favorite
S-104
Model-Informed Dose Selection for mRNA-3927 in Participants with Propionic Acidemia (PA)

Favorite
T-113
Model-informed Evidence Generation to Optimize Warfarin Dosing for Hepatic Impairment

Favorite
S-103
Model-Informed Oral Tacrolimus Dose Optimization for Adult Recipients of Allogeneic Hematopoietic Cell Transplantation Receiving Post-Transplant Cyclophosphamide

Favorite
S-045
Model-informed scheduling of drug combinations for optimal treatment of cancer: a case study of JDQ443 and TNO155 dose regimen optimization

Favorite
M-084
Modeling Blood Urea Nitrogen (urea) Dynamics to Estimate Dialysis Adequacy

Favorite
M-084
Modeling Blood Urea Nitrogen (urea) Dynamics to Estimate Dialysis Adequacy

Favorite
T-048
Modeling clinical trial design in infectious disease outbreaks considering differences in IC50 between in vitro and in vivo

Favorite
S-036
Modeling for prediction of CCR8 receptor occupancy in human tumor tissues after dosing of S-531011, a humanized anti-CCR8 monoclonal antibody

Favorite
T-058
Modeling Huntington’s disease progression utilizing the Huntington’s disease integrated staging system

Favorite
M-081
Modeling Interactions Between Respiratory Pathogens

Favorite
S-067
Moment closure for uncertainty propagation in QSP models

Favorite
T-049
Monte-Carlo simulations to assess isavuconazole probability of pharmacokinetic-pharmacodynamic target attainment (PTA) for Chinese pediatric patients with invasive aspergillosis (IA) or invasive mucormycosis (IM)

Favorite
T-017
Multi-Objective Optimization for Population Pharmacokinetic Model Selection: Evaluating Non-dominated Sorting Genetic Algorithm III Performance

Favorite
M-014
Multiple myeloma QSP model enables evaluation of iberdomide dosing schedules post-ASCT in NDMM patients for the EXCALIBER Maintenance study

Favorite